Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|November 30, 2019
The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer CellsYu-Liang Li, Hao-Cheng Weng, Jui-Ling Hsu, et al.
Frontiers in Pharmacology|December 18, 2018
Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and -Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol ContentsJui-Ling Hsu, Wohn-Jenn Leu, Lih-Ching Hsu, et al.
The Journal of Urology|March 23, 2011
Costunolide induces apoptosis through nuclear calcium2+ overload and DNA damage response in human prostate cancerJui-Ling Hsu, Shiow-Lin Pan, Yunn-Fang Ho, et al.
The Prostate|July 2, 2013
A novel hydroxysuberamide derivative potentiates MG132-mediated anticancer activity against human hormone refractory prostate cancers--the role of histone deacetylase and endoplasmic reticulum stressYi-Cheng Chen, Wei-Jan Huang, Jui-Ling Hsu, et al.
Biochemical Pharmacology|April 12, 2012
Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCδ-independent pathwayJui-Ling Hsu, Yunn-Fang Ho, Tsai-Kun Li, et al.
Journal of Biomedical Science|January 8, 2015
KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activityChia-Chun Yu, Shih-Ping Liu, Jui-Ling Hsu, et al.
The Prostate|January 7, 2020
Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na<sup>+</sup> /K<sup>+</sup> -ATPase internalization and tubulin acetylationWohn-Jenn Leu, Ching-Ting Wang, Jui-Ling Hsu, et al.
Frontiers in Pharmacology|June 6, 2022
The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling PathwaysHao-Cheng Weng, Chieh-Ju Sung, Jui-Ling Hsu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 10, 2014
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathwayJui-Ling Hsu, Shih-Ping Liu, Chia-Chung Lee, et al.
European Journal of Pharmacology|March 11, 2014
Calanquinone A induces anti-glioblastoma activity through glutathione-involved DNA damage and AMPK activationFan-Lun Liu, Jui-Ling Hsu, Yean-Jang Lee, et al.
Pageof 5